<SEC-DOCUMENT>0001062993-25-015817-index.html : 20250926 <SEC-HEADER>0001062993-25-015817.hdr.sgml : 20250926 <ACCEPTANCE-DATETIME>20250926131704 ACCESSION NUMBER: 0001062993-25-015817 CONFORMED SUBMISSION TYPE: SCHEDULE 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250926 DATE AS OF CHANGE: 20250926 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: abrdn Life Sciences Investors CENTRAL INDEX KEY: 0000884121 ORGANIZATION NAME: EIN: 043147016 STATE OF INCORPORATION: MA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SCHEDULE 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48561 FILM NUMBER: 251348706 BUSINESS ADDRESS: STREET 1: 1900 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 6177728515 MAIL ADDRESS: STREET 1: 1900 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: TEKLA LIFE SCIENCES INVESTORS DATE OF NAME CHANGE: 20141015 FORMER COMPANY: FORMER CONFORMED NAME: H&Q LIFE SCIENCES INVESTORS DATE OF NAME CHANGE: 19920929 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Saba Capital Management, L.P. CENTRAL INDEX KEY: 0001510281 ORGANIZATION NAME: EIN: 800361690 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A BUSINESS ADDRESS: STREET 1: 405 LEXINGTON AVENUE STREET 2: 58TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 BUSINESS PHONE: 212-542-4635 MAIL ADDRESS: STREET 1: 405 LEXINGTON AVENUE STREET 2: 58TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13D/A <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-4 <SEQUENCE>2 <FILENAME>exhibit4.htm <DESCRIPTION>EXHIBIT 4 <TEXT> Document 2 - file: exhibit4.htm
</DOCUMENT> </SEC-DOCUMENT>